What Changed
Cyabra Inc. filed its S-1 with the SEC on October 8, 2026, initiating the registration process for a US public offering. The filing size runs 12 MB, consistent with a full disclosure package including financials, risk factors, and use-of-proceeds detail. No priced range or share count was disclosed in the initial filing, which is standard at this stage.
The Numbers That Matter
| Filing Stage | Typical Timeline | Investor Access | Price Discovery |
|---|---|---|---|
| S-1 initial filing | Day 0 | None (pre-roadshow) | Undisclosed |
| S-1/A amendments | 30 to 90 days out | Institutional only | Range disclosed |
| Roadshow | 1 to 2 weeks pre-IPO | Institutional, select retail | Range narrows |
| Pricing and listing | Day of IPO | Public | Final price set |
At this stage, there is no tradable security and no price. The S-1 is a disclosure event, not an entry point. Institutional channels and syndicate relationships, rather than open market orders, typically control allocation access if any exists.
What This Means for Your Portfolio
For a reader holding a $1.5M portfolio with a 5% allocation to pre-IPO or thematic small-cap tech ($75,000), this filing represents a watchlist event. Capital deployed before pricing and lockup terms are disclosed carries unquantifiable downside, since no financial history is visible in public summaries beyond the filing's existence. The decision point typically arrives 90 to 180 days out, once the prospectus prices the deal.
Scenario Analysis
| Position Size | Speculative IPO Allocation (5%) | Day-1 Pop Scenario (plus 20%) | Day-1 Drop Scenario (minus 20%) |
|---|---|---|---|
| $500K | $25,000 | $30,000 | $20,000 |
| $1M | $50,000 | $60,000 | $40,000 |
| $2M | $100,000 | $120,000 | $80,000 |
These figures assume full allocation at IPO price, a scenario unavailable to most individual investors without institutional access. Capital gains tax on short-term positions varies by state. At federal rates alone (20% for long-term gains, ordinary income rates up to 37% for short-term), plus state taxes that range from 0% to 13.3% depending on jurisdiction, the effective rate can materially reduce net proceeds. For illustrative purposes only, assuming a 37% combined federal and state rate on a short-term $1M position with a 20% day-one gain, net proceeds would be approximately $18,900 rather than $30,000. The downside case creates a loss position with no offsetting tax benefit unless harvested against other gains.
Frequently Asked Questions
Q: Does an S-1 filing mean Cyabra stock is available to buy now? A: No, an S-1 only begins the registration process and typically precedes actual trading by 60 to 120 days.
Q: What is the minimum net worth typically needed to access pre-IPO allocation? A: Most syndicate and institutional allocation channels require accredited investor status, which starts at a $1M net worth excluding primary residence or $200,000 in annual individual income.
Q: How is IPO day-one gain taxed for a high-net-worth investor? A: Shares sold within 12 months of acquisition face taxation as short-term capital gains at ordinary income rates, which reach 37% at the federal level alone. State taxes add incremental burden varying by jurisdiction (0% to 13.3%).
Q: What happens to my position if there is a post-IPO lockup period? A: Insider and early allocation shares typically face restrictions from sale for 90 to 180 days post-listing, during which the position cannot be liquidated regardless of price movement.
Run the Numbers
Use CalcMoney's Calculate Your After-Tax RSU Proceeds to see your exact figures under the current tax threshold.
This article is for informational purposes only and does not constitute professional financial advice. Consult a qualified tax advisor or financial professional regarding your specific circumstances before making investment decisions.
Run the Numbers: Capital Gains Tax Terminal on CalcMoney — see your exact figures under current market conditions.
You Might Also Like
- S-1/A Files S-1: RSU & Capital Gains Tax Exposure Calculator — Aug 10, 2026
- Latigo Biotherapeutics, Inc. Files Amended S-1: RSU & Capital Gains Tax Exposure Calculator (Aug 3, 2026)
- market briefing ipo filing 2026 08 04
- Pinnacle Acquisition Corp Files Amended S-1: RSU & Capital Gains Tax Exposure Calculator (Aug 5, 2026)
Data sourced from SEC EDGAR S-1 Filings (IPO). Rates and thresholds are for informational purposes only. Consult a licensed financial advisor before making mortgage, investment, or tax decisions.
Put These Numbers to Work
Open a Fidelity brokerage account. $0 commissions, no account minimums, fractional shares available.
Affiliated. We may earn a commission.
Related Guides
Free Tools
Run the actual numbers
Stop estimating. Plug in your numbers and get a precise answer in seconds. Free, no signup required.
Open the Capital Gains Calculator


